This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Zajecka, John
| Item Type | Name |
|
Concept
|
Serotonin
|
|
Concept
|
Receptors, Serotonin
|
|
Concept
|
Serotonin Antagonists
|
|
Academic Article
|
SNRIs in the management of acute major depressive disorder.
|
|
Academic Article
|
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
|
|
Academic Article
|
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
|
|
Academic Article
|
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.
|
|
Academic Article
|
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression.
|
|
Academic Article
|
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
|
|
Academic Article
|
Residual symptoms in major depressive disorder: prevalence, effects, and management.
|
|
Academic Article
|
Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.
|
|
Academic Article
|
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
|
|
Academic Article
|
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
|
|
Academic Article
|
Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study.
|
|
Academic Article
|
The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
|
|
Academic Article
|
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
|
|
Academic Article
|
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
|
|
Academic Article
|
Clinical management of antidepressant discontinuation.
|
|
Academic Article
|
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
|
|
Academic Article
|
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
|
|
Academic Article
|
Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
|
|
Academic Article
|
Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
|
|
Academic Article
|
Changes in weight during a 1-year trial of fluoxetine.
|
|
Academic Article
|
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
|
|
Academic Article
|
Strategies for the treatment of antidepressant-related sexual dysfunction.
|
|
Academic Article
|
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
|